Global Pneumococcal Conjugate Vaccine (PCV) Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Pneumococcal Conjugate Vaccine (PCV) Market Size was estimated at USD 4266.11 million in 2023 and is projected to reach USD 5153.60 million by 2029, exhibiting a CAGR of 3.20% during the forecast period.
This report provides a deep insight into the global Pneumococcal Conjugate Vaccine (PCV) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pneumococcal Conjugate Vaccine (PCV) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pneumococcal Conjugate Vaccine (PCV) market in any manner.
Global Pneumococcal Conjugate Vaccine (PCV) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Zhifei Biologic
Serum Institute of India
Market Segmentation (by Type)
23-valent Vaccine
10-valent Vaccine
7-valent Vaccine
13-valent Vaccine
Market Segmentation (by Application)
Child
Adult
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pneumococcal Conjugate Vaccine (PCV) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Pneumococcal Conjugate Vaccine (PCV) Market Size was estimated at USD 4266.11 million in 2023 and is projected to reach USD 5153.60 million by 2029, exhibiting a CAGR of 3.20% during the forecast period.
This report provides a deep insight into the global Pneumococcal Conjugate Vaccine (PCV) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pneumococcal Conjugate Vaccine (PCV) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pneumococcal Conjugate Vaccine (PCV) market in any manner.
Global Pneumococcal Conjugate Vaccine (PCV) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Pfizer
GSK
Sanofi
Merck
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Zhifei Biologic
Serum Institute of India
Market Segmentation (by Type)
23-valent Vaccine
10-valent Vaccine
7-valent Vaccine
13-valent Vaccine
Market Segmentation (by Application)
Child
Adult
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Pneumococcal Conjugate Vaccine (PCV) Market
- Overview of the regional outlook of the Pneumococcal Conjugate Vaccine (PCV) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pneumococcal Conjugate Vaccine (PCV) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pneumococcal Conjugate Vaccine (PCV)
1.2 Key Market Segments
1.2.1 Pneumococcal Conjugate Vaccine (PCV) Segment by Type
1.2.2 Pneumococcal Conjugate Vaccine (PCV) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET COMPETITIVE LANDSCAPE
3.1 Global Pneumococcal Conjugate Vaccine (PCV) Sales by Manufacturers (2019-2024)
3.2 Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Manufacturers (2019-2024)
3.3 Pneumococcal Conjugate Vaccine (PCV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pneumococcal Conjugate Vaccine (PCV) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pneumococcal Conjugate Vaccine (PCV) Sales Sites, Area Served, Product Type
3.6 Pneumococcal Conjugate Vaccine (PCV) Market Competitive Situation and Trends
3.6.1 Pneumococcal Conjugate Vaccine (PCV) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pneumococcal Conjugate Vaccine (PCV) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) INDUSTRY CHAIN ANALYSIS
4.1 Pneumococcal Conjugate Vaccine (PCV) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Type (2019-2024)
6.3 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2019-2024)
6.4 Global Pneumococcal Conjugate Vaccine (PCV) Price by Type (2019-2024)
7 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Sales by Application (2019-2024)
7.3 Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD) by Application (2019-2024)
7.4 Global Pneumococcal Conjugate Vaccine (PCV) Sales Growth Rate by Application (2019-2024)
8 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET SEGMENTATION BY REGION
8.1 Global Pneumococcal Conjugate Vaccine (PCV) Sales by Region
8.1.1 Global Pneumococcal Conjugate Vaccine (PCV) Sales by Region
8.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Region
8.2 North America
8.2.1 North America Pneumococcal Conjugate Vaccine (PCV) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pneumococcal Conjugate Vaccine (PCV) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pneumococcal Conjugate Vaccine (PCV) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Pneumococcal Conjugate Vaccine (PCV) Basic Information
9.1.2 Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Overview
9.1.3 Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Pneumococcal Conjugate Vaccine (PCV) SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 GSK
9.2.1 GSK Pneumococcal Conjugate Vaccine (PCV) Basic Information
9.2.2 GSK Pneumococcal Conjugate Vaccine (PCV) Product Overview
9.2.3 GSK Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Pneumococcal Conjugate Vaccine (PCV) SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi
9.3.1 Sanofi Pneumococcal Conjugate Vaccine (PCV) Basic Information
9.3.2 Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Overview
9.3.3 Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
9.3.4 Sanofi Pneumococcal Conjugate Vaccine (PCV) SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Merck
9.4.1 Merck Pneumococcal Conjugate Vaccine (PCV) Basic Information
9.4.2 Merck Pneumococcal Conjugate Vaccine (PCV) Product Overview
9.4.3 Merck Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
9.4.4 Merck Business Overview
9.4.5 Merck Recent Developments
9.5 Walvax Biotechnology
9.5.1 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Basic Information
9.5.2 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Overview
9.5.3 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
9.5.4 Walvax Biotechnology Business Overview
9.5.5 Walvax Biotechnology Recent Developments
9.6 Royal (Wuxi) Bio-Pharmaceutical
9.6.1 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Basic Information
9.6.2 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Overview
9.6.3 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
9.6.4 Royal (Wuxi) Bio-Pharmaceutical Business Overview
9.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments
9.7 Zhifei Biologic
9.7.1 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Basic Information
9.7.2 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Overview
9.7.3 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
9.7.4 Zhifei Biologic Business Overview
9.7.5 Zhifei Biologic Recent Developments
9.8 Serum Institute of India
9.8.1 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Basic Information
9.8.2 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Overview
9.8.3 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
9.8.4 Serum Institute of India Business Overview
9.8.5 Serum Institute of India Recent Developments
10 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET FORECAST BY REGION
10.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast
10.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country
10.2.3 Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Region
10.2.4 South America Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pneumococcal Conjugate Vaccine (PCV) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pneumococcal Conjugate Vaccine (PCV) by Type (2025-2030)
11.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pneumococcal Conjugate Vaccine (PCV) by Type (2025-2030)
11.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Forecast by Application (2025-2030)
11.2.1 Global Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons) Forecast by Application
11.2.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pneumococcal Conjugate Vaccine (PCV)
1.2 Key Market Segments
1.2.1 Pneumococcal Conjugate Vaccine (PCV) Segment by Type
1.2.2 Pneumococcal Conjugate Vaccine (PCV) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET COMPETITIVE LANDSCAPE
3.1 Global Pneumococcal Conjugate Vaccine (PCV) Sales by Manufacturers (2019-2024)
3.2 Global Pneumococcal Conjugate Vaccine (PCV) Revenue Market Share by Manufacturers (2019-2024)
3.3 Pneumococcal Conjugate Vaccine (PCV) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pneumococcal Conjugate Vaccine (PCV) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pneumococcal Conjugate Vaccine (PCV) Sales Sites, Area Served, Product Type
3.6 Pneumococcal Conjugate Vaccine (PCV) Market Competitive Situation and Trends
3.6.1 Pneumococcal Conjugate Vaccine (PCV) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pneumococcal Conjugate Vaccine (PCV) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) INDUSTRY CHAIN ANALYSIS
4.1 Pneumococcal Conjugate Vaccine (PCV) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Type (2019-2024)
6.3 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Market Share by Type (2019-2024)
6.4 Global Pneumococcal Conjugate Vaccine (PCV) Price by Type (2019-2024)
7 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Sales by Application (2019-2024)
7.3 Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD) by Application (2019-2024)
7.4 Global Pneumococcal Conjugate Vaccine (PCV) Sales Growth Rate by Application (2019-2024)
8 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET SEGMENTATION BY REGION
8.1 Global Pneumococcal Conjugate Vaccine (PCV) Sales by Region
8.1.1 Global Pneumococcal Conjugate Vaccine (PCV) Sales by Region
8.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Region
8.2 North America
8.2.1 North America Pneumococcal Conjugate Vaccine (PCV) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pneumococcal Conjugate Vaccine (PCV) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pneumococcal Conjugate Vaccine (PCV) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Pfizer
9.1.1 Pfizer Pneumococcal Conjugate Vaccine (PCV) Basic Information
9.1.2 Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Overview
9.1.3 Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
9.1.4 Pfizer Business Overview
9.1.5 Pfizer Pneumococcal Conjugate Vaccine (PCV) SWOT Analysis
9.1.6 Pfizer Recent Developments
9.2 GSK
9.2.1 GSK Pneumococcal Conjugate Vaccine (PCV) Basic Information
9.2.2 GSK Pneumococcal Conjugate Vaccine (PCV) Product Overview
9.2.3 GSK Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Pneumococcal Conjugate Vaccine (PCV) SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Sanofi
9.3.1 Sanofi Pneumococcal Conjugate Vaccine (PCV) Basic Information
9.3.2 Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Overview
9.3.3 Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
9.3.4 Sanofi Pneumococcal Conjugate Vaccine (PCV) SWOT Analysis
9.3.5 Sanofi Business Overview
9.3.6 Sanofi Recent Developments
9.4 Merck
9.4.1 Merck Pneumococcal Conjugate Vaccine (PCV) Basic Information
9.4.2 Merck Pneumococcal Conjugate Vaccine (PCV) Product Overview
9.4.3 Merck Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
9.4.4 Merck Business Overview
9.4.5 Merck Recent Developments
9.5 Walvax Biotechnology
9.5.1 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Basic Information
9.5.2 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Overview
9.5.3 Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
9.5.4 Walvax Biotechnology Business Overview
9.5.5 Walvax Biotechnology Recent Developments
9.6 Royal (Wuxi) Bio-Pharmaceutical
9.6.1 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Basic Information
9.6.2 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Overview
9.6.3 Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
9.6.4 Royal (Wuxi) Bio-Pharmaceutical Business Overview
9.6.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments
9.7 Zhifei Biologic
9.7.1 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Basic Information
9.7.2 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Overview
9.7.3 Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
9.7.4 Zhifei Biologic Business Overview
9.7.5 Zhifei Biologic Recent Developments
9.8 Serum Institute of India
9.8.1 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Basic Information
9.8.2 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Overview
9.8.3 Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Market Performance
9.8.4 Serum Institute of India Business Overview
9.8.5 Serum Institute of India Recent Developments
10 PNEUMOCOCCAL CONJUGATE VACCINE (PCV) MARKET FORECAST BY REGION
10.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast
10.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country
10.2.3 Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Region
10.2.4 South America Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pneumococcal Conjugate Vaccine (PCV) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Pneumococcal Conjugate Vaccine (PCV) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pneumococcal Conjugate Vaccine (PCV) by Type (2025-2030)
11.1.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pneumococcal Conjugate Vaccine (PCV) by Type (2025-2030)
11.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Forecast by Application (2025-2030)
11.2.1 Global Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons) Forecast by Application
11.2.2 Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pneumococcal Conjugate Vaccine (PCV) Market Size Comparison by Region (M USD)
Table 5. Global Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pneumococcal Conjugate Vaccine (PCV) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Conjugate Vaccine (PCV) as of 2022)
Table 10. Global Market Pneumococcal Conjugate Vaccine (PCV) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pneumococcal Conjugate Vaccine (PCV) Sales Sites and Area Served
Table 12. Manufacturers Pneumococcal Conjugate Vaccine (PCV) Product Type
Table 13. Global Pneumococcal Conjugate Vaccine (PCV) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pneumococcal Conjugate Vaccine (PCV)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pneumococcal Conjugate Vaccine (PCV) Market Challenges
Table 22. Global Pneumococcal Conjugate Vaccine (PCV) Sales by Type (Kilotons)
Table 23. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (M USD)
Table 24. Global Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons) by Type (2019-2024)
Table 25. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Type (2019-2024)
Table 26. Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD) by Type (2019-2024)
Table 27. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Share by Type (2019-2024)
Table 28. Global Pneumococcal Conjugate Vaccine (PCV) Price (USD/Ton) by Type (2019-2024)
Table 29. Global Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons) by Application
Table 30. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Application
Table 31. Global Pneumococcal Conjugate Vaccine (PCV) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Application (2019-2024)
Table 33. Global Pneumococcal Conjugate Vaccine (PCV) Sales by Application (2019-2024) & (M USD)
Table 34. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2019-2024)
Table 35. Global Pneumococcal Conjugate Vaccine (PCV) Sales Growth Rate by Application (2019-2024)
Table 36. Global Pneumococcal Conjugate Vaccine (PCV) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Region (2019-2024)
Table 38. North America Pneumococcal Conjugate Vaccine (PCV) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Pneumococcal Conjugate Vaccine (PCV) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Pneumococcal Conjugate Vaccine (PCV) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Pneumococcal Conjugate Vaccine (PCV) Basic Information
Table 44. Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 45. Pfizer Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Pneumococcal Conjugate Vaccine (PCV) SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. GSK Pneumococcal Conjugate Vaccine (PCV) Basic Information
Table 50. GSK Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 51. GSK Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Pneumococcal Conjugate Vaccine (PCV) SWOT Analysis
Table 54. GSK Recent Developments
Table 55. Sanofi Pneumococcal Conjugate Vaccine (PCV) Basic Information
Table 56. Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 57. Sanofi Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Pneumococcal Conjugate Vaccine (PCV) SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Merck Pneumococcal Conjugate Vaccine (PCV) Basic Information
Table 62. Merck Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 63. Merck Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Merck Business Overview
Table 65. Merck Recent Developments
Table 66. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Basic Information
Table 67. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 68. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Walvax Biotechnology Business Overview
Table 70. Walvax Biotechnology Recent Developments
Table 71. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Basic Information
Table 72. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 73. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Royal (Wuxi) Bio-Pharmaceutical Business Overview
Table 75. Royal (Wuxi) Bio-Pharmaceutical Recent Developments
Table 76. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Basic Information
Table 77. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 78. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Zhifei Biologic Business Overview
Table 80. Zhifei Biologic Recent Developments
Table 81. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Basic Information
Table 82. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 83. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Serum Institute of India Business Overview
Table 85. Serum Institute of India Recent Developments
Table 86. Global Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 87. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 89. North America Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 91. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 93. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 95. South America Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 99. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Pneumococcal Conjugate Vaccine (PCV) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 101. Global Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons) Forecast by Application (2025-2030)
Table 102. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pneumococcal Conjugate Vaccine (PCV) Market Size Comparison by Region (M USD)
Table 5. Global Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pneumococcal Conjugate Vaccine (PCV) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumococcal Conjugate Vaccine (PCV) as of 2022)
Table 10. Global Market Pneumococcal Conjugate Vaccine (PCV) Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pneumococcal Conjugate Vaccine (PCV) Sales Sites and Area Served
Table 12. Manufacturers Pneumococcal Conjugate Vaccine (PCV) Product Type
Table 13. Global Pneumococcal Conjugate Vaccine (PCV) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pneumococcal Conjugate Vaccine (PCV)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pneumococcal Conjugate Vaccine (PCV) Market Challenges
Table 22. Global Pneumococcal Conjugate Vaccine (PCV) Sales by Type (Kilotons)
Table 23. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Type (M USD)
Table 24. Global Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons) by Type (2019-2024)
Table 25. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Type (2019-2024)
Table 26. Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD) by Type (2019-2024)
Table 27. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Share by Type (2019-2024)
Table 28. Global Pneumococcal Conjugate Vaccine (PCV) Price (USD/Ton) by Type (2019-2024)
Table 29. Global Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons) by Application
Table 30. Global Pneumococcal Conjugate Vaccine (PCV) Market Size by Application
Table 31. Global Pneumococcal Conjugate Vaccine (PCV) Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Application (2019-2024)
Table 33. Global Pneumococcal Conjugate Vaccine (PCV) Sales by Application (2019-2024) & (M USD)
Table 34. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2019-2024)
Table 35. Global Pneumococcal Conjugate Vaccine (PCV) Sales Growth Rate by Application (2019-2024)
Table 36. Global Pneumococcal Conjugate Vaccine (PCV) Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Region (2019-2024)
Table 38. North America Pneumococcal Conjugate Vaccine (PCV) Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Pneumococcal Conjugate Vaccine (PCV) Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Pneumococcal Conjugate Vaccine (PCV) Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Sales by Region (2019-2024) & (Kilotons)
Table 43. Pfizer Pneumococcal Conjugate Vaccine (PCV) Basic Information
Table 44. Pfizer Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 45. Pfizer Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Pfizer Business Overview
Table 47. Pfizer Pneumococcal Conjugate Vaccine (PCV) SWOT Analysis
Table 48. Pfizer Recent Developments
Table 49. GSK Pneumococcal Conjugate Vaccine (PCV) Basic Information
Table 50. GSK Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 51. GSK Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Pneumococcal Conjugate Vaccine (PCV) SWOT Analysis
Table 54. GSK Recent Developments
Table 55. Sanofi Pneumococcal Conjugate Vaccine (PCV) Basic Information
Table 56. Sanofi Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 57. Sanofi Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Sanofi Pneumococcal Conjugate Vaccine (PCV) SWOT Analysis
Table 59. Sanofi Business Overview
Table 60. Sanofi Recent Developments
Table 61. Merck Pneumococcal Conjugate Vaccine (PCV) Basic Information
Table 62. Merck Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 63. Merck Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Merck Business Overview
Table 65. Merck Recent Developments
Table 66. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Basic Information
Table 67. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 68. Walvax Biotechnology Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Walvax Biotechnology Business Overview
Table 70. Walvax Biotechnology Recent Developments
Table 71. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Basic Information
Table 72. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 73. Royal (Wuxi) Bio-Pharmaceutical Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Royal (Wuxi) Bio-Pharmaceutical Business Overview
Table 75. Royal (Wuxi) Bio-Pharmaceutical Recent Developments
Table 76. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Basic Information
Table 77. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 78. Zhifei Biologic Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Zhifei Biologic Business Overview
Table 80. Zhifei Biologic Recent Developments
Table 81. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Basic Information
Table 82. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Product Overview
Table 83. Serum Institute of India Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Serum Institute of India Business Overview
Table 85. Serum Institute of India Recent Developments
Table 86. Global Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 87. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Region (2025-2030) & (M USD)
Table 88. North America Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 89. North America Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country (2025-2030) & (M USD)
Table 90. Europe Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 91. Europe Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country (2025-2030) & (M USD)
Table 92. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Region (2025-2030) & (Kilotons)
Table 93. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Region (2025-2030) & (M USD)
Table 94. South America Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Country (2025-2030) & (Kilotons)
Table 95. South America Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country (2025-2030) & (M USD)
Table 96. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Consumption Forecast by Country (2025-2030) & (Units)
Table 97. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Country (2025-2030) & (M USD)
Table 98. Global Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Type (2025-2030) & (Kilotons)
Table 99. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Type (2025-2030) & (M USD)
Table 100. Global Pneumococcal Conjugate Vaccine (PCV) Price Forecast by Type (2025-2030) & (USD/Ton)
Table 101. Global Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons) Forecast by Application (2025-2030)
Table 102. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pneumococcal Conjugate Vaccine (PCV)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD), 2019-2030
Figure 5. Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD) (2019-2030)
Figure 6. Global Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (M USD)
Figure 11. Pneumococcal Conjugate Vaccine (PCV) Sales Share by Manufacturers in 2023
Figure 12. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Share by Manufacturers in 2023
Figure 13. Pneumococcal Conjugate Vaccine (PCV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pneumococcal Conjugate Vaccine (PCV) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pneumococcal Conjugate Vaccine (PCV) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Type
Figure 18. Sales Market Share of Pneumococcal Conjugate Vaccine (PCV) by Type (2019-2024)
Figure 19. Sales Market Share of Pneumococcal Conjugate Vaccine (PCV) by Type in 2023
Figure 20. Market Size Share of Pneumococcal Conjugate Vaccine (PCV) by Type (2019-2024)
Figure 21. Market Size Market Share of Pneumococcal Conjugate Vaccine (PCV) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application
Figure 24. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Application (2019-2024)
Figure 25. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Application in 2023
Figure 26. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2019-2024)
Figure 27. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application in 2023
Figure 28. Global Pneumococcal Conjugate Vaccine (PCV) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Region (2019-2024)
Figure 30. North America Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Country in 2023
Figure 32. U.S. Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Pneumococcal Conjugate Vaccine (PCV) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Country in 2023
Figure 37. Germany Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Region in 2023
Figure 44. China Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (Kilotons)
Figure 50. South America Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Country in 2023
Figure 51. Brazil Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pneumococcal Conjugate Vaccine (PCV) Market Share Forecast by Type (2025-2030)
Figure 65. Global Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Application (2025-2030)
Figure 66. Global Pneumococcal Conjugate Vaccine (PCV) Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Pneumococcal Conjugate Vaccine (PCV)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD), 2019-2030
Figure 5. Global Pneumococcal Conjugate Vaccine (PCV) Market Size (M USD) (2019-2030)
Figure 6. Global Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pneumococcal Conjugate Vaccine (PCV) Market Size by Country (M USD)
Figure 11. Pneumococcal Conjugate Vaccine (PCV) Sales Share by Manufacturers in 2023
Figure 12. Global Pneumococcal Conjugate Vaccine (PCV) Revenue Share by Manufacturers in 2023
Figure 13. Pneumococcal Conjugate Vaccine (PCV) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pneumococcal Conjugate Vaccine (PCV) Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pneumococcal Conjugate Vaccine (PCV) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Type
Figure 18. Sales Market Share of Pneumococcal Conjugate Vaccine (PCV) by Type (2019-2024)
Figure 19. Sales Market Share of Pneumococcal Conjugate Vaccine (PCV) by Type in 2023
Figure 20. Market Size Share of Pneumococcal Conjugate Vaccine (PCV) by Type (2019-2024)
Figure 21. Market Size Market Share of Pneumococcal Conjugate Vaccine (PCV) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application
Figure 24. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Application (2019-2024)
Figure 25. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Application in 2023
Figure 26. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application (2019-2024)
Figure 27. Global Pneumococcal Conjugate Vaccine (PCV) Market Share by Application in 2023
Figure 28. Global Pneumococcal Conjugate Vaccine (PCV) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Region (2019-2024)
Figure 30. North America Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Country in 2023
Figure 32. U.S. Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Pneumococcal Conjugate Vaccine (PCV) Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Pneumococcal Conjugate Vaccine (PCV) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Country in 2023
Figure 37. Germany Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Region in 2023
Figure 44. China Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (Kilotons)
Figure 50. South America Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Country in 2023
Figure 51. Brazil Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Pneumococcal Conjugate Vaccine (PCV) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Pneumococcal Conjugate Vaccine (PCV) Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Pneumococcal Conjugate Vaccine (PCV) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pneumococcal Conjugate Vaccine (PCV) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pneumococcal Conjugate Vaccine (PCV) Market Share Forecast by Type (2025-2030)
Figure 65. Global Pneumococcal Conjugate Vaccine (PCV) Sales Forecast by Application (2025-2030)
Figure 66. Global Pneumococcal Conjugate Vaccine (PCV) Market Share Forecast by Application (2025-2030)
